Recall: Anti-Anxiety Drug Packaged With Defective Droppers

This article originally appeared here.
Share this content:
Amneal has notified its wholesalers and pharmacies via a letter arranging for supply replacement.
Amneal has notified its wholesalers and pharmacies via a letter arranging for supply replacement.

Amneal announced a voluntary recall of 13 lots of Lorazepam Oral Concentrate 2mg/mL due to an error in the dropper markings.

The dosing droppers, supplied by a third party, were misprinted with the dose markings in reverse number, shifted dose markings or no dose markings. The product was packaged in individual cartons with the NDC 65162-687-84 containing 30mL glass bottles of liquid; the plastic dropper is sealed in a clear plastic bag. The affected product Lot # and expiration dates are as follows:

Lot Number 

 Expiration Date 

06876016A

08/2018

06876017A

08/2018

06876018A

08/2018

06876019A

09/2018

06876020A

09/2018

06876021A

09/2018

06876022A

09/2018

06876023A

11/2018

06876024A

12/2018

06876025A

12/2018

06877001A

02/2019

06877002A

02/2019

06877003A

03/2019

Lorazepam Oral Concentrate, a CIV controlled substance, is indicated for the management of anxiety disorders, for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms

Use of the droppers with marking errors can lead to a dose that is either greater than or less than the prescribed dose. Potentially serious adverse events associated with a higher than prescribed dose include drowsiness causing trauma, increased anxiety, increased accidental injury to self or others (eg, hip fracture, motor vehicle accident), permanent decreased function, or death.

Amneal has notified its wholesalers and pharmacies via a letter arranging for supply replacement. The Company has not received any adverse events related to the defective droppers. 

Reference

Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product [press release]. Amneal Pharmaceuticals. http://www.amneal.com/news/. Published August 14, 2017. Accessed August 21, 2017.

You must be a registered member of Psychiatry Advisor to post a comment.